Therapeutic targeting of folate receptor-beta expressing tumor-associated macrophages.
Therapeutic targeting of folate receptor-beta expressing tumor-associated macrophages.
批准号:
20790377
负责人:
NAGAI Taku
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009
中文摘要
近年来,临床和实验研究表明,炎性巨噬细胞,如肿瘤相关巨噬细胞(tumor-associated macrophages,TAMs)在恶性肿瘤中发挥重要作用。我们发现类风湿性关节炎的滑膜巨噬细胞表达叶酸受体β(FRβ),而正常组织和外周血单核细胞中的组织驻留巨噬细胞不表达或表达低水平的FRβ。我们在人恶性肿瘤和裸鼠移植瘤模型中检测了TAM是否表达FRβ,如果是,选择性清除表达FRβ的TAM是否能抑制裸鼠移植瘤模型中的肿瘤生长,我们的结果显示表达FRβ的TAM具有以下新特征:(a)免疫组化分析显示,表达FRβ的TAM存在于胶质母细胞瘤、肺癌和胰腺癌中;(B)同样,在植入大鼠C6胶质瘤模型的裸鼠中存在表达FRβ的TAM;(由重链和轻链Fv部分和假单胞菌外毒素A组成)导入裸鼠中的C6胶质瘤异种移植物中显著地耗尽TAM并降低肿瘤生长和CD 31阳性血管面积;(4)免疫毒素在体外抑制表达FRβ的巨噬细胞产生NO和VEGF,提示表达FRβ的TAMs可能促进胶质母细胞瘤的生长,提示靶向表达FRβ的巨噬细胞可能是一种有效的抗肿瘤治疗方法。
英文摘要
Recently, clinical and experimental evidence suggested that inflammatory macrophages, such as tumor-associated macrophages (TAMs) play important role in malignant tumors. We have shown that synovial macrophages in rheumatoid arthritis express folate receptor β (FRβ) while tissue resident macrophages in normal tissues and peripheral blood monocytes express no or low levels of FRβ. We tested whether TAMs express FRβ in human malignant tumors and nude mice xenograft model and if so, whether selectively elimination of FRβ-expressing TAMs could suppress tumor growth in nude mice model.Our results showed the following novel features of FRβ-expressing TAMs : (a) immunohistochemical analysis revealed that FRβ-expressing TAMs were present in glioblastoma, lung cancer, and pancreatic cancer; (b) also, FRβ-expressing TAMs were present in nude mice implanted with rat C6 glioma model; (c) injection of the anti-FRβ immunotoxin (consisting of heavy and light chain Fv portions and Pseudomonas exotoxin A) into C6 glioma xenografts in nude mice significantly depleted TAMs and reduced tumor growth and CD31-positive vascular area; (d) immunotoxin inhibited NO and VEGF production by FRβ-expressing macrophages in vitro.Our study indicated that FRβ-expressing TAMs may promote tumor growth in glioblastoma, and suggested that targeting FRβ-expressing macrophages could be an effective anti-cancer therapy method.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
がん増殖の抑制と抗炎症作用を示す低分子高機能型抗体(イムノトキシン)科学技術振興機構
抑制癌症生长并具有抗炎作用的低分子高功能抗体(免疫毒素) 日本科学技术振兴机构
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Nagai T., Tanaka M., K Hasui, Shiramaha H., Kitajima S., Yonezawa S., Xu B., Matsuyama T., 永井拓]
通讯作者:
永井拓
Targeting tumor-associated macrophages in an experiment al glioma model with a recombinant immunotoxin to folat e receptor beta
使用重组免疫毒素靶向实验神经胶质瘤模型中的肿瘤相关巨噬细胞以叶酸受体β
DOI:
--
发表时间:
2009
期刊:
Cancer Immunol Immunother (Online published)
影响因子:
--
作者:
[Nagai T, Tanaka M, Tsuneyoshi Y, Xu B, Michie SA, Hasui K, Hirano H, Arito K, Matsuyama T]
通讯作者:
Matsuyama T
肺線維症マウスにおける葉酸リセプターβ発現マクロファージの選択的除去の効果
选择性耗竭表达叶酸受体β的巨噬细胞对肺纤维化小鼠的影响
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[Nagai T., Tanaka M., K Hasui, Shiramaha H., Kitajima S., Yonezawa S., Xu B., Matsuyama T., 永井拓, 永井拓, 永井拓, 永井拓, 永井拓, 永井拓, 永井拓]
通讯作者:
永井拓
Limited distribution of folate-receptor beta expressing inflammatory macrophages in murine tissues
表达叶酸受体β的炎症巨噬细胞在小鼠组织中的有限分布
DOI:
--
发表时间:
2008
期刊:
Mod Rheumatol 18(S)
影响因子:
--
作者:
[Nagai T, Tanaka M, Matsuyama T.]
通讯作者:
Matsuyama T.
間質性肺炎治療剤
间质性肺炎治疗剂
DOI:
--
发表时间:
2009
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 15 条
Study on the neurodevelopmental abnormalities induced by the innate immune activation during perinatal period
-
批准号:25460093
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2013
-
负责人:NAGAI Taku
-
依托单位:
ROLE OF TRANSCRIPTION FACTOR NPAS4 IN DRUG DEPENDENCE
-
批准号:23790081
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.83万
-
财政年份:2011
-
负责人:NAGAI Taku
-
依托单位:
Identification of drug target for novel antipsychotics based on proteomic approach
-
批准号:21790067
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.83万
-
财政年份:2009
-
负责人:NAGAI Taku
-
依托单位:
Proteomics analysis in schizophrenia
-
批准号:19790053
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.28万
-
财政年份:2007
-
负责人:NAGAI Taku
-
依托单位:
海外基金